Dental Hygienist 9th Edition
by Elena Bablenis Haveles, Chapters 1 - 26 A+
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription
Writing
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
MULTIPLE CHOICE
1. Knowledge of pharmacology aids the dental professional in
a. obtaining a patient’s health history.
b. administering drugs in the office.
c. handling emergency situations.
d. selection of a nonprescription medicatio
n.
e. All of the above.
ANSWER: E
All of the choices are true. Because many of our patients are being treated with drugs, knowled
ge of pharmacology helps in understanding and interpreting patients’ responses to health history q
uestions. Knowledge of the therapeutic and adverse effects of medications obviously helps in th
eir proper administration in the office. Emergency situations may be caused by drugs or treated
by drugs; thus, knowledge of pharmacology is of great help, especially because a rapid respons
e is sometimes required. A clear understanding of the concepts of drug action, drug handling b
y the body, and drug interactions will allow the dental practitioner to make proper judgments a
nd grasp the concepts relevant to new drug therapies on the market.
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medi
cation Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hy
gienist (Nonprescription Medication) | pp. 2-3 OBJ: 1
TOP: NBDHE, 6.0. Pharmacology
2. Which of the following statements is true regarding planning appointments?
a. Whether or not patients are taking medication for systemic diseases is of l
ittle
consequence in the dental office.
b. Asthmatic patients should have dental appointments in the morning.
c. Diabetic patients usually have fewer problems with a morning appointment
compared with afternoon appointments.
d. Both B and C are true.
ANSWER: D
Asthmatic patients who experience dental anxiety should schedule their appointments when they a
re not rushed or under pressure early in the morning. Diabetic patients usually have relatively f
ewer problems with a morning appointment. Patients taking medication for systemic diseases may
,require special handling in the dental office.
, DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |
p. 3 OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
3. Nutritional or herbal supplements
a. carry the U.S. Food and Drug Administration (FDA) approval for disease sta
tes.
b. are not drugs.
c. can cause adverse effects.
d. will not interact with other drugs the patient may be taking.
ANSWER: C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majori
ty of nutritional or herbal supplements do not carry FDA approval for treating disease sta
tes. These supplements are drugs and can cause adverse effects and interact with differen
t drugs.
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements)
| p. 3 OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
4. Which type of drug name usually begins with a lowercase letter?
a. Brand name
b. Code name
c. Generic name
d. Trade name
ANSWER: C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the
drug. Each drug is assigned only one generic name selected by the U.S. Adopted Name Counci
l, and the name is not capitalized. The brand name is equivalent to the trade name and is capita
lized. Although the brand name is technically the name of the company marketing the product, th
is term is often used interchangeably with the trade name. The code name is the initial term use
d within a pharmaceutical company to refer to a drug while it is undergoing investigation and i
s often a combination of capital letters and numbers, the letters representing an abbreviation of
the company name.
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3
TOP: NBDHE, 6.0. Pharmacology
5. A drug’s generic name is selected by the
a. pharmaceutical company manufacturing it
.
b. Food and Drug Administration (FDA).
c. U.S. Adopted Name Council.
d. Federal Patent Office.